John J. Kearns

All filings by John J. Kearns on record concern Integramed America Inc. We count 2 filings, every one of them for a trade on 20 September 2012.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 20 September 2012 came the latest disclosure, an option exercise in Integramed America Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.